IP Library Granted Patent US 10,307,511
Granted Patent B2
US 10,307,511 · App. 15/586,929 · Granted Jun 4, 2019

Bioactive composites of polymer and glass and method for making same

Inventors: Theodore D. Clineff (Phoenixville, PA); Marissa M. Conrad (Philadelphia, PA); Matthew B. Havener (West Conshohocken, PA); James P. Murphy (Newtown Square, PA); Zachary S. Szczerbinski (Turnersville, NJ)
Assignee: Orthovita, Inc.
A61L27/446A61B17/742A61B17/80A61B17/86A61C8/0012A61C8/0016A61F2/28A61F2/2803A61F2/2875A61F2/30734A61F2/30771A61F2/32A61F2/446A61F2/447A61F2/4455A61F2/4465A61F2/4611A61L27/54A61L31/128B29C47/0004B29C47/1027B29C47/822C08K3/40A61F2002/2882A61F2002/30062A61F2002/3082A61F2002/3085A61F2002/30131A61F2002/30738A61F2002/30787A61F2002/30828A61F2002/30892A61F2002/448A61F2002/4475A61F2002/4622A61F2002/4631A61F2002/4681A61F2210/0004A61F2230/0013A61F2310/00329A61L2430/02A61L2430/38B29B9/06B29B9/12B29C45/0001B29K2071/00B29K2105/126B29K2105/16B29K2509/08B29K2995/0056B29L2031/7532C08G2650/40C08K2201/005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,307,511
App. No.
15/586,929
Granted
Jun 4, 2019
Kind
B2
Abstract

The present invention generally relates to bioactive composites of polymer and glass and, more particularly, to bioactive implants. The present invention also relates to methods of manufacturing bioactive composites. The bioactive composite finds utility in a variety of load-bearing clinical applications including spine, orthopaedic and dental procedures.

Claims (5)

1. A non-resorbable bioactive composite, comprising:

a homogeneous mixture of a polyetheretherketone (PEEK)polymer and

alkali-containing bioactive glass particles,

wherein the PEEK polymer has a particle size of from 1,000 μm to 4,000 μm and is present in an amount of 70% to 80% by weight of the composite, and

wherein the alkali-containing bioactive glass particles are 45S5 or Combeite glass-ceramic and have a particle size range from 50 μm to 250 μm and are present in an amount of 20% to 30% by weight of the composite.

Assignments (3)
CHANGE OF ADDRESS Recorded Dec 18, 2024
From: STRYKER CORPORATION
To: STRYKER CORPORATION
Reel/Frame 069737/0184 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 1, 2023
From: ORTHOVITA, INC.
To: STRYKER CORPORATION
Reel/Frame 065735/0360 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2017
From: CLINEFF, THEODORE D.; CONRAD, MARISSA M.; HAVENER, MATTHEW B.; MURPHY, JAMES P.; SZCZERBINSKI, ZACHARY S.
To: ORTHOVITA, INC.
Reel/Frame 042634/0732 →
Continuity (4)
Continuation 14699333 · Apr 29, 2015
Continuation 12577835 · Oct 13, 2009
Provisional Application 61141453 · Dec 30, 2008
Related Publication 20170232147A1 · Aug 17, 2017